R2032629 |
GDC-0349 |
GDC-0349 is a potent and selective ATP-competitive mTOR inhibitor with a Ki of 3
|
R2032630 |
GSK-J4 |
GSK-J4 is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and U
|
R2032631 |
GSK2838232 |
|
R2032632 |
KN-92 hydrochloride |
KN-92 hydrochloride is an inactive derivative of KN-93.KN-93 is a selective inhi
|
R2032633 |
KNK437 |
KNK437 is a HSP inhibitor, and inhibits the induction of HSP105, HSP70, and HSP4
|
R2032634 |
Cligosiban(PF-3274167) |
Cligosiban (PF-3274167), a high oral bioavailability and good brain-penetrant no
|
R2032635 |
SANT-1 |
SANT-1 is a potent Smo antagonist, inhibits Hedgehog signaling, with IC50s of 20
|
R2032636 |
SB239063 |
SB 239063 is a potent, selective and orally active p38 MAPK inhibitor, exhibits
|
R2032637 |
AEE788(NVP-AEE788) |
AEE788 is an inhibitor of the EGFR and ErbB2 with IC50 values of 2 and 6 nM, res
|
R2032638 |
DDR1-IN-1 |
DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with
|
R2032639 |
Decernotinib(VX-509) |
Decernotinib is a potent, orally active JAK3 inhibitor, with Kis of 2.5, 11, 13
|
R2032640 |
EGF816;Nazartinib |
Nazartinib (EGF816) is a novel, covalent mutant-selective EGFR inhibitor, with K
|
R2032641 |
GSK5959 |
GSK-5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor w
|
R2032642 |
MK8245 |
MK-8245 is a potent, liver-targeted stearoyl-CoA desaturase (SCD) inhibitor, wit
|
R2032643 |
NS6180 |
NS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50= 9 nM) prev
|
R2032644 |
OF-1 |
OF-1 is a selective BRPF1B and BRPF2 bromodomain inhibitor with Kd values of 100
|
R2032645 |
RQ-00203078 |
RQ-00203078 is a highly selective, potent and orally available TRPM8 antagonist
|
R2032646 |
T-5224 |
T-5224 is a transcription factor c-Fos/activator protein (AP)-1 inhibitor with a
|
R2032647 |
TCS5861528 |
Chembridge-5861528 is a TRPA1 channel blocker that antagonizes AITC- and 4-HNE-e
|
R2032648 |
UNC0224 |
UNC0224 is a potent and selective G9a inhibitor with IC50 of 15 nM in the G9a Th
|
R2032649 |
VER155008 |
VER-155008 is an inhibitor of Hsp70, with IC50s of 0.5 μM, 2.6 μM, and 2.6 μM fo
|
R2032650 |
Vorapaxar;SCH530348 |
Vorapaxar (SCH 530348), an antiplatelet agent, is a selective, orally active, an
|
R2032651 |
Voreloxin(SNS-595;AG 7352) |
Voreloxin (SNS-595; Vosaroxin; AG 7352) is a first-in-class topoisomerase II inh
|
R2032652 |
ZM447439 |
ZM-447439 is an aurora kinase inhibitor with IC50s of 110 and 130 nM for aurora
|
R2032653 |
CCT244747 |
CCT244747 is a potent, orally bioavailable and highly selective CHK1 inhibitor,
|